Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Eye cancer is a rare disease where cancer cells form in the tissues of or around the eye. This can include cancers that start inside the eyeball, such as melanoma (from pigment-producing cells), carcinoma (from surface tissues like the eyelid), lymphoma (from immune system cells), and retinoblastoma, which is a rare cancer that usually affects young children’s retinas. Eye cancer can also involve tumors that spread to the eye from other parts of the body, though this is less common.
Because the eye is a delicate organ important for vision, eye cancers require careful diagnosis and treatment to try to preserve sight while controlling the cancer. Different types of eye cancer behave differently and may need different treatments. For example, retinoblastoma mainly affects children and may require specialized care, while melanoma is more common in adults. Understanding the type and location of the cancer helps doctors plan the best treatment and follow-up care.
Patients may notice symptoms like blurred vision, a dark spot on the iris, changes in pupil size, or a white or yellow glow in a child’s eye. Sometimes eye cancer is found during a routine eye exam before symptoms appear. Genetic testing may be done on tumor samples to look for changes in genes like BAP1, which can give doctors clues about the cancer’s behavior or inherited risk. Patients might hear terms like “uveal melanoma,” “retinoblastoma,” or “intraocular lymphoma” depending on the cancer type.
The term “eye cancer” may appear in medical records, pathology reports, genetic test results, treatment plans, or clinical trial information. It may also come up in discussions about inherited cancer risk if genetic changes are found. Because eye cancer covers many different tumors, the exact meaning depends on the context and the specific diagnosis.
Hearing “eye cancer” does not mean the same thing for every patient. It does not automatically indicate a specific type, stage, or treatment plan. It also does not mean the cancer will behave the same way in all people. Some eye tumors are benign (noncancerous), and even among cancers, some grow slowly while others may be more aggressive. Genetic findings like BAP1 mutations do not alone decide treatment but may be one piece of information doctors use.
Doctors use the diagnosis of eye cancer to guide tests, treatment, and monitoring. They may perform eye exams, imaging, biopsies, and genetic tests to understand the cancer’s type and behavior. Treatment options can include surgery, radiation, laser therapy, or freezing and heat treatments. Genetic information, such as BAP1 gene changes, may help assess inherited risk or guide treatment decisions, especially in clinical trials or specialized centers.
Because eye cancer involves many types and complex terms, patients and caregivers may feel confused. It can be hard to understand how genetics relate to cancer risk or treatment. Patients might wonder what the diagnosis means for their vision, treatment options, or family members. It’s important to ask the care team to explain what eye cancer means for the individual, what tests are planned, and what to expect from treatment.
This information is meant to help patients and caregivers understand eye cancer in general. It does not replace personalized medical advice. If you see the term “eye cancer” in your medical records or hear it from your doctor, the best next step is to ask your healthcare team to explain what it means for your specific case. They can help you understand your diagnosis, treatment options, and any genetic findings in context.
If you or a loved one has been told about eye cancer, consider preparing questions for your care team. Ask about the type of cancer, treatment choices, possible side effects, and how the cancer might affect vision. If genetic testing is done, ask what the results mean for you and your family. Getting clear, personalized information can help you make informed decisions and feel more confident in your care.
Public source information used for this glossary entry includes: